Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738733015 | Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738734014 | Acetaminophen and butalbital and caffeine and codeine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738735010 | Butalbital and caffeine and codeine and paracetamol only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | est un(e) (attribut) | Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | est un(e) (attribut) | Acetaminophen and butalbital and caffeine and codeine only product | true | Inferred relationship | Some | ||
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | a pour principe actif (attribut) | Acetaminophen | true | Inferred relationship | Some | 3 | |
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | a pour principe actif (attribut) | Butalbital (substance) | true | Inferred relationship | Some | 4 | |
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | a pour principe actif (attribut) | Caffeine | true | Inferred relationship | Some | 1 | |
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | a pour principe actif (attribut) | Codeine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | Count of base of active ingredient | quatre | false | Inferred relationship | Some | ||
| Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | Plays role | Antitussive therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | True | Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR